Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative ...
Singapore has a similarly ambitious target to reach net zero by 2050 – with the crucial difference that the industries most ...
NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
ServiceNow's acquisition of Logik.ai represents the company's continued strategic expansion into the CRM space, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results